About
Envomed addresses the environmental and health risks posed by improper disposal of medical waste. Traditional methods, such as incineration and landfilling, contribute to pollution and increase the risk of exposure to harmful pathogens and chemicals.
Envomed provides an on-site medical waste treatment system that processes waste directly within healthcare facilities. This system neutralizes pathogens and reduces the waste volume, transforming hazardous medical waste into non-hazardous material that can be safely disposed of using conventional methods. By eliminating the need for incineration or external treatment, Envomed's solution reduces environmental impact and helps lower waste management costs for healthcare providers
Envomed is developed by Maabarot Metalworks Ltd
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Envomed founded?
- Envomed was founded in September 1999.
- What is Envomed's primary product?
- Envomed's primary product is the Envomed 80, an on-site medical waste treatment system.
- What is Envomed's core business model?
- Envomed operates on a B2B business model, providing its medical waste treatment system to other businesses.
- In which geographic markets does Envomed have a presence?
- Envomed has a presence in Asia, Europe, and Israel.
- Which organization granted Envomed funding in February 2024?
- In February 2024, Envomed received a grant from the IIA (Israel Innovation Authority).
- What is the approximate employee count for Envomed?
- Envomed has an employee count of 7.
- What is the primary sector classification for Envomed?
- Envomed's primary sector classification is Industrial Technologies.
- What is Envomed's alternative name?
- Envomed is also known as Maabarot Metal Works or MMW.